The Tricky Trachea: Tracheitis and Mediastinitis Treated With Infliximab and Steroids in a Patient With Ulcerative Colitis.
Adult
Antirheumatic Agents
/ administration & dosage
Biopsy
/ methods
Bronchoscopy
/ methods
Colitis, Ulcerative
/ diagnosis
Diagnosis, Differential
Drug Administration Routes
Drug Monitoring
/ methods
Female
Humans
Infliximab
/ administration & dosage
Mediastinitis
/ diagnostic imaging
Steroids
/ administration & dosage
Tomography, X-Ray Computed
/ methods
Trachea
/ pathology
Tracheitis
/ diagnostic imaging
Treatment Outcome
Ultrasonography, Interventional
/ methods
inflammatory
manifestation
mediastinitis
tracheitis
Journal
Chest
ISSN: 1931-3543
Titre abrégé: Chest
Pays: United States
ID NLM: 0231335
Informations de publication
Date de publication:
09 2021
09 2021
Historique:
received:
04
02
2021
revised:
23
03
2021
accepted:
25
03
2021
entrez:
7
9
2021
pubmed:
8
9
2021
medline:
7
1
2022
Statut:
ppublish
Résumé
Pulmonary extra-intestinal manifestations of inflammatory bowel disease are rare, comprising 0.21% to 0.4% of the inflammatory bowel disease population. Common symptoms include cough, chest pain, and dyspnea. Abnormal pulmonary function tests are common in these patients, with restrictive, obstructive, and diffusion capacity defects. CT scanning remains the most sensitive imaging technique to detect abnormalities. Pulmonary manifestations are diverse and include airway, parenchymal, and pleural disease. Large airway disease predominates, particularly bronchiectasis. Upper airway disease is rare but concerning for the development of acute airway compromise. To our knowledge, there are no reports of concurrent mediastinitis with tracheitis in the setting of inflammatory bowel disease. We present a case of a patient with ulcerative proctitis who experienced the development of inflammatory tracheitis and mediastinitis. Her disease responded to systemic steroids and biologic therapy. In addition to our case, we reviewed the literature and provide an approach to pulmonary complications as extra-intestinal manifestation of inflammatory bowel disease.
Identifiants
pubmed: 34488963
pii: S0012-3692(21)00677-2
doi: 10.1016/j.chest.2021.03.060
pii:
doi:
Substances chimiques
Antirheumatic Agents
0
Steroids
0
Infliximab
B72HH48FLU
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e255-e258Informations de copyright
Copyright © 2021 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.